Accelerant (ARX) Registration Filing summary
Event summary combining transcript, slides, and related documents.
Registration Filing summary
29 Nov, 2025Company overview and business model
Operates a data-driven risk exchange connecting specialty insurance underwriters (MGAs) with risk capital partners, leveraging proprietary technology and analytics to reduce inefficiencies in the insurance value chain.
As of March 31, 2025, platform includes 232 Members and 96 risk capital partners, with operations in over 20 countries and $3.5B in Exchange Written Premium for the trailing twelve months.
Revenue is generated through three segments: Exchange Services (fee-based), MGA Operations (commissions and equity income from owned/incubated MGAs), and Underwriting (retained risk and ceding commissions).
Focuses on low-limit, low-hazard, specialty commercial risks, with a selective onboarding process for MGAs and a capital-light model.
Financial performance and metrics
Exchange Written Premium grew 53% year-over-year to $2.05–$2.06B for the six months ended June 30, 2025; Adjusted EBITDA expected to be $100–$105M, up 153% from prior year period.
For the year ended December 31, 2024: revenues $602.6M (+75% YoY), net income $22.9M (vs. net loss $64.1M in 2023), Adjusted EBITDA $113M (vs. $36.1M in 2023).
Gross loss ratios: 53% (Q1 2025), 54% (2024), 51% (2023); Net revenue retention 157% (Q1 2025).
As of March 31, 2025: total assets $6.7B, equity $454.4M, debt $121.5M, debt/capitalization ratio 21%.
Use of proceeds and capital allocation
Net proceeds of $355.1M (at $19.00/share IPO price) to be used for redemption of $175.3M Class C convertible preference shares (if not converted), $25M one-time termination fee to Altamont Capital, and remainder for general corporate purposes and potential acquisitions.
No proceeds from shares sold by selling shareholders; company may use funds for investments in MGAs, insurance intermediaries, technology, or service providers.
Latest events from Accelerant
- FY 2025 saw 35% premium growth, 149% EBITDA increase, and a $200M buyback plan.ARX
Q4 202519 Mar 2026 - Executive agreements set high base pay, strong severance, equity, and compliance terms.ARX
Registration Filing29 Nov 2025 - Tech-driven specialty insurance platform targets growth with IPO, but faces execution and regulatory risks.ARX
Registration Filing29 Nov 2025 - Q2 2025 delivered 42% premium growth, 29% EBITDA margin, and a return to profitability.ARX
Q2 202523 Nov 2025 - Adjusted EBITDA up 302% and Exchange Written Premium up 17% year-over-year.ARX
Q3 202514 Nov 2025 - Rapid growth, strong margins, and AI-driven efficiency define this specialty insurance platform.ARX
Investor Presentation11 Sep 2025